What question did this study set out to answer?

To evaluate the impact of statin therapy on clinical prognosis, inflammatory activation, and left ventricular myocardial performance assessed by Tissue Doppler Imaging in chronic heart failure.

January 1, 2011ClinicsOpen Access

Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry

View Full Paper

Ask AI

Bookmark

Why the study?

Does statin therapy improve prognosis, inflammatory activation, and left ventricular performance in outpatients with chronic ischemic heart failure?

Key Points

To evaluate the impact of statin therapy on clinical prognosis, inflammatory activation, and left ventricular myocardial performance assessed by Tissue Doppler Imaging in chronic heart failure.
Retrospectively analyzed 353 consecutive outpatients with chronic heart failure from the Daunia Heart Failure Registry over a mean follow-up of 384 days.
Assessed left ventricular function using Tissue Doppler Imaging parameters and measured circulating levels of interleukin-6, interleukin-10, and C-reactive protein.
Statin use in 128 subjects with ischemic heart disease was associated with lower rates of heart failure rehospitalization (15% vs. 46%, p<0.001), ventricular arrhythmias (5% vs. 21%, p<0.01), and cardiac death (1% vs. 8%, p<0.05).
Statin-treated patients had lower circulating IL-6 (p<0.05) and IL-10 (p<0.01), along with improved Tissue Doppler metrics, including a reduced E/E' ratio (12.82 ± 5.42 vs. 19.85 ± 9.14, p<0.001) and prolonged ejection time (260.62 ± 44.16 vs. 227.11 ± 37.58 ms, p<0.05).

Structured PICO

Does statin therapy improve prognosis, inflammatory activation, and left ventricular performance in outpatients with chronic ischemic heart failure?

Population

353 consecutive outpatients with chronic heart failure enrolled in the local Daunia Heart Failure Registry (results specifically highlight 128 subjects with ischemic heart disease)

Intervention

Statin therapy

Comparator

No statin therapy

Outcome

Prognosis (adverse events including rehospitalization for HF, ventricular arrhythmias, cardiac death), inflammatory activation (IL-6, IL-10, C-reactive protein), and myocardial performance evaluated by Tissue Doppler Imaging

In outpatients with chronic ischemic heart failure, statin therapy is associated with reduced adverse events, decreased inflammation, and improved left ventricular function as assessed by Tissue Doppler Imaging.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support statin use in ischemic HF outpatients; hypothesis-generating and requires RCT confirmation before practice change.

Cite This Study

Correale et al. (2011) studied this question.

synapsesocial.com/papers/6a7153538031ec7bb1dce4d7 https://doi.org/10.1590/s1807-59322011000500012

Topics

Statin therapy Heart failure HFrEF treatment Women and heart disease HFpEF management

View Full Paper

Ask AI

Bookmark

Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider